Immunoregulatory impact of food antioxidants

Current Pharmaceutical Design

Volumn 20, Issue 6, 2014, Pages 840-849

  Gostner, Johanna ^a   Ciardi, Christian ^a   Becker, Kathrin ^a   Fuchs, Dietmar ^a   Sucher, Robert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antioxidant; Neopterin; Nitric oxide; Th1 Th2 type immune balance; Tryptophan

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; MITOGENIC AGENT;

ALLERGY; ASTHMA; CELL STIMULATION; CULTURAL ANTHROPOLOGY; EPIDEMIC; FOOD; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LUNG FUNCTION; MACROPHAGE; MONOCYTE; MOOD; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TH1 TH2 BALANCE;

ANIMALS; ANTIOXIDANTS; ASTHMA; DIET; DIETARY SUPPLEMENTS; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; INFLAMMATION; OBESITY;

EID: 84895105024     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990047     Document Type: Review

References (121)

1. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004; 113: 395-400.
2. Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy 2009; 39: 1314-23.
3. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158: 670-89.
4. Duramad P, Holland NT. Biomarkers of immunotoxicity for environmental and public health research. Int J Environ Res Public Health 2011; 8: 1388-401.
5. Li JT. Allergy testing. Am Fam Physician 2002; 15(66): 621-4.
6. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1-8.
7. Lane HC, Masur H, Gelmann EP, et al. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med 1985; 78: 417-22.
8. Fuchs D, Hausen A, Reibnegger G, et al. Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 1989; 2: 158-62.
9. Fan J, Bass HZ, Fahey JL. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993; 151: 5031-40.
10. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G, Wachter H. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol Lett 1989; 23: 103-8.
11. Widner B, Ledochowski M, Fuchs D. Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. Curr Drug Metabol 2000; 1: 193-204.
12. Sperner-Unterweger B, Kohl C, Fuchs D. Immune changes and catecholamines: is there a role in depression? Prog Neuropsychopharmacol Biol Psych (in press).
13. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metabol 2002; 3: 175-87.
14. Schroecksnadel S, Kurz K, Weiss G, Fuchs D. Immune activation and neuropsychiatric symptoms in HIV-1 infection. Neurobehav HIV Res 2011; 3: 1-13.
15. Werner ER, Bitterlich G, Fuchs D, et al. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci 1987; 41: 273-80.
16. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991; 5: 2516-22.
17. Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/ psychiatric symptoms. J Acquir Immune Defic Syndr 1990; 3: 873-6.
18. Fuchs D, Möller AA, Reibnegger G, Werner ER, et al. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett 1991; 28: 207-12.
19. Denz H, Fuchs D, Hausen A, et al. Value of urinary neopterin in the differential diagnosis of bacterial and viral infections. Klin Wochenschr 1990; 68: 218-22.
20. Leblhuber F, Walli J, Demel U, Tilz GP, Widner B, Fuchs D. Increased serum neopterin concentrations in patients with Alzheimer's disease. Clin Chem Lab Med 1999; 37: 429-31.
21. Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D, Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett 2010; 287: 13-22.
22. Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005; 26: 457-63.
23. Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consuegra Sanchez L, Kaski JC. The role of neopterin in atherogenesis and cardiovascular risk stratification. Curr Med Chem 2009; 16: 4644-53.
24. Grammer TB, Fuchs D, Böhm BO, Winkelmann BR, Maerz W. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography (The Ludwigshafen Risk and Cardiovascular Health Study). Clin Chem 2010; 55: 115-46.
25. Pedersen ER, Midttun Ø, Ueland PM, et al. Systemic markers of interferon-_-mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol 2011; 31: 698-704.
26. Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease and healthy states. International J Tryptophan Res 2009: 2: 1-19.
27. Schroecksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006; 364: 82-90.
28. Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D. Neopterin production tryptophan degradation and mental depression: what is the link? Brain Behav Immun 2002; 16: 590-5.
29. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002; 25: 154-9.
30. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.
31. Schroecksnadel K, Fischer B, Schennach H, Weiss G, Fuchs D. Antioxidants down-regulate Th1-type immune response in vitro. Drug Metabol Lett 2007; 1: 166-71.
32. Jenny M, Klieber M, Zaknun D, et al. In vitro testing for antiinflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm Res 2011; 60: 127-35.
33. Mayersbach P, Augustin R, Schennach H, et al. Commercial enzyme-linked immunosorbent assay for neopterin detection in blood donations compared with RIA and HPLC. Clin Chem 1994; 40: 265-6.
34. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43: 2424-6.
35. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 200; 10: 1343-74.
36. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997; 82: 91-5.
37. Vertuani S, Angusti A, Manfredini S. The antioxidants and proantioxidants network: an overview. Curr Pharm Des 2004; 10: 1677-94.
38. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J 2010; 9:3.
39. Murr C, Schroecksnadel K, Winklhofer-Roob BM, et al. Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis 2009; 202: 543-9.
40. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860-72.
41. Bjelakovic G, Nikolova, D, Gluud, LL, Simonetti, RG, Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. J Am Med Assoc 2007; 297: 842-57.
42. Milner JD, Stein DM, McCarter R, Moon RY. Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma. Pediatrics 2004; 114: 27-32.
43. Hyppönen E, Sovio U, Wjst M, et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci 2004; 1037: 84-95.
44. Snodgrass SR. Vitamin neurotoxicity. Mol Neurobiol 1992; 6: 41-73.
45. Lanska DJ. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. Handb Clin Neurol 2010; 95: 445-76.
46. Ebbing M, Bønaa KH, Nygård O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. J Am Med Assoc 2009; 302: 2119-26.
47. Roswall N, Olsen A, Christensen J, et al. Micronutrient intake in relation to all-cause mortality in a prospective Danish cohort. Food Nutr Res 2012; 56.
48. Fuchs D, Sperner-Unterweger B. Can intake of extra antioxidants delay the development and progression of atherosclerosis? Atherosclerosis 2013; 226: 43-4.
49. Weiss G, Murr C, Zoller H, et al. Modulation of neopterin formation and tryptophan degradation by Th1-and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999; 116: 435-40.
50. Schroecksnadel S, Sucher R, Kurz K, Fuchs, Brandacher G. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells. Transplant Immunol 2011; 25: 119-23.
51. Schroecksnadel S, Maier E, Jenny M, Kurz K, Ueberall F, Fuchs D. Beeinflussung immunologischer Regelkreise durch Nahrungsmittelzusatzstoffe wie Konservierungsmittel und Farbstoffe in vitro. Allergologie 2011; 34: 200-11.
52. Stevenson DE, Hurst RD. Polyphenolic phytochemicals--just antioxidants or much more? Cell Mol Life Sci 2007: 64: 2900-16.
53. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NFkappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247-58.
54. Schroecksnadel S, Jenny M, Kurz K, et al. LPS-induced NFkappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem Biophys Res Com 2010; 399: 642-6.
55. Prasad S, Phromnoi K, Yadav VR, Chaturvedi MM, Aggarwal BB. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med 2010; 76: 1044-63.
56. Allan K, Kelly FJ, Devereux G. Antioxidants and allergic disease: a case of too little or too much? Clin Exp Allergy 2010; 40: 370-80.
57. van der Vliet A, O'Neill CA, Cross CE, et al. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. Am J Physiol 1999; 276: L289-96.
58. Kelly FJ, Cotgrove M, Mudway IS. Respiratory tract lining fluid antioxidants: the first line of defence against gaseous pollutants. Cent Eur J Public Health 1996; 4: 11-4.
59. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandström T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354: 482-3.
60. Sackesen C, Ercan H, Dizdar E, et al. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J Allergy Clin Immunol 2008; 122: 78-85.
61. Mudway IS, Stenfors N, Blomberg A, et al. Differences in basal airway antioxidant concentrations are not predictive of individual responsiveness to ozone: a comparison of healthy and mild asthmatic subjects. Free Radic Biol Med 2001; 31: 962-74.
62. Caramori G, Papi A. Oxidants and asthma. Thorax 2004; 59: 170-3.
63. Seaton A, Godden DJ, Brown K. Increase in asthma: a more toxic environment or a more susceptible population? Thorax1994; 49: 171-4.
64. Allan K, Devereux G. Diet and asthma: nutrition implications from prevention to treatment. J Am Diet Assoc 2011; 111: 258-68.
65. Tashakkor AY, Chow KS, Carlsten C. Modification by antioxidant supplementation of changes in human lung function associated with air pollutant exposure: a systematic review. BMC Public Health 2011; 11: 532.
66. Tricon, S, Willers S, Smit HA, et al. Nutrition and allergic disease. Clin Exp Allergy Rev 2006; 6: 117-88.
67. Behndig AF, Blomberg A, Helleday R, Kelly FJ, Mudway IS. Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C. Inhal Toxicol 2009; 21: 250-8.
68. Mudway IS, Stenfors N, Duggan ST, et al. An in vitro and in vivo investigation of the effects of diesel exhaust on human airway lining fluid antioxidants. Arch Biochem Biophys 2004; 423: 200-12.
69. Douwes J, Brooks C, van Dalen C, Pearce N. Importance of allergy in asthma: an epidemiologic perspective. Curr Allergy Asthma Rep 2011; 11: 434-44.
70. Strachan DP. Hay fever, hygiene, and household size. Brit Med J 1989; 299: 1259-60.
71. Brooks C, Pearce N, Douwes J. The hygiene hypothesis in allergy and asthma: an update. Curr Opin Allergy Clin Immunol 2013; 13: 70-7.
72. Zaknun D, Schroecksnadel S, Kurz K, Fuchs D. Potential role of antioxidant food supplements, preservatives and colorants in the pathogenesis of allergy and asthma. Int Arch Allergy Immunol 2012; 157: 113-24.
73. von Bubnoff D, Bieber T. The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy. Allergy 2012; 67: 718-25.
74. Ciprandi G, Fuchs D. Tryptophan, neopterin and nitrite in allergy. Allergy 2012; 67: 1083.
75. Kositz C, Schroecksnadel K, Grander G, Schennach H, Kofler H, Fuchs D. Serum tryptophan concentration in patients predicts outcome of specific immunotherapy with pollen extracts. Int Arch Allergy Immunol 2008; 147: 35-40.
76. Ciprandi G, Amici M, Tosca M, Fuchs D. Tryptophan metabolism in allergic rhinitis: the effect of pollen allergen exposure. Hum Immunol 2010; 71: 911-5.
77. Ciprandi G, De Amici M, Tosca M, Fuchs D, Marseglia G. Serotonin in allergic rhinitis: a role for behavioural symptoms. Iran J Allergy Asthma Immunol 2011; 10: 183-8.
78. Aytekin M, Dweik RA. Nitric oxide and asthma severity: towards a better understanding of asthma phenotypes. Clin Exp Allergy 2012; 42: 614-6.
79. Ciprandi G, Tosca M, Fuchs D. Nitric oxide metabolites in allergic rhinitis: the effect of pollen allergen exposure. Allergol Immunopathol 2011; 39: 326-9.
80. Thomas SR, Terentis AC, Cai H, et al. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem 2007; 282: 23778-87.
81. Hesslinger C, Strub A, Boer R, Ulrich WR, Lehner MD, Braun C. Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans 2009; 37: 886-91.
82. Wink DA, Hines HB, Cheng RY, et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 2011; 89: 873-91.
83. Elmore AR. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics. Int J Toxicol 2005; 24 (Suppl 2): 51-111.
84. Nanditha B, Prabhasankar P. Antioxidants in bakery products: a review. Crit Rev Food Sci Nutr 2009; 49: 1-27.
85. Nair B, Elmore AR. Cosmetic Ingredients Review Expert Panel. Final report on the safety assessment of sodium sulfite, potassium sulfite, ammonium sulfite, sodium bisulfite, ammonium bisulfite, sodium metabisulfite and potassium metabisulfite. Int J Toxicol 2003; 22 (Suppl 2): 63-88.
86. Nair B. Final report on the safety assessment of benzyl alcohol, benzoic acid, and sodium benzoate. Int J Toxicol 2001; 20 (Suppl 3): 23-50.
87. International Programme on Chemical Safety (INCHEM). Concise International chemical assessment document no. 26. Available from: http://www.inchem.org/documents/cicads/cicads/cicad26.htm#Sect ionNumber:4.1. [Accessed January 2013].
88. Burdock GA. Fenaroli's Handbook of Flavour Ingredients. 5th ed. CRC Press. 2004.
89. Maier E, Kurz K, Jenny M, Schennach H, Ueberall F, Fuchs D. Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in vitro. Food Chem Toxicol 2010; 48: 1950-6.
90. Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. Curcumin--from molecule to biological function. Angew Chem Int Ed Engl 2012; 51: 5308-32.
91. Winkler C, Wirleitner B, Schroecksnadel K, Schennach H, Fuchs D. In vitro effects of beet root juice on stimulated and unstimulated peripheral blood mononuclear cells. Am J Biochem Biotechnol 2005; 1: 181-6.
92. Vinson JA, Hao Y, Su C, Zubic L. Phenol antioxidant quantity and quality in foods: vegetables. J. Agric. Food Chem 1998; 46: 3630-4.
93. Gliszczy-ska-Swig-o A, Szymusiak H, Malinowska P. Betanin, the main pigment of red beet: molecular origin of its exceptionally high free radical-scavenging activity. Food Addit Contam 2006; 23: 1079-87.
94. He FJ, Nowson CA, Lucas M, MacGregor GA. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens 2007; 21: 717-28.
95. Snel J, Born L, van der Meer R. Dietary fish oil impairs induction of gamma-interferon and delayed-type hypersensitivity during a systemic Salmonella enteritidis infection in rats. APMIS 2010; 118: 578-84.
96. Tan PH, Sagoo P, Chan C, et al. Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 2005; 174: 7633-44.
97. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158: 670-89.
98. Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 2011; 208: 417-20.
99. Murata Y, Shimamura T, Hamuro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 2002; 14: 201-12.
100. Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Brit J Cancer 2002; 86: 1691-6.
101. Capuron L, Neurauter G, Musselman DL, et al. Interferon-alphainduced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol Psychiatry 2003; 54: 906-14.
102. Capuron L, Schroecksnadel S, Féart C, et al. Chronic low grade immune activation in the elderly is associated with increased tryptophan catabolism and altered phenylalanine turnover: role in neuropsychiatric symptomatology. Biol Psych 2011; 70: 175-82.
103. Capuron L, Moranis A, Combe N, et al. Vitamin E status and quality of life in the elderly: influence of inflammatory processes. Br J Nutr 2009; 102: 1390-4.
104. Mangge H, Fuchs D, Freytag F, Weghuber D, Almer G, Haj-Yahya S. Serum neopterin is not increased in obese juveniles. J Obes 2011; 2011: 946795.
105. Rogers PJ. A healthy body, a healthy mind: long-term impact of diet on mood and cognitive function. Proc Nutr Soc 2001; 60: 135-43.
106. Harris E, Kirk J, Rowsell R, et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol 2011; 26: 560-7.
107. Zvetkova E, Wirleitner B, Tram NT, Schennach H, Fuchs D. Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. Intern Immunopharmacol 2001; 1: 2143-50.
108. Jenny M, Santer E, Klein A, et al. Cacao extracts suppress tryptophan degradation of mitogen-stimulated peripheral blood mononuclear cells. J Ethnopharmacol 2009; 207: 75-82.
109. Poljsak B, Milisav I. The neglected significance of antioxidative stress. Oxid Med Cell Longev 2012; 2012:480895.
110. Vincent HK, Bourguignon CM, Taylor AG. Relationship of the dietary phytochemical index to weight gain, oxidative stress and inflammation in overweight young adults. J Hum Nutr Diet 2010; 23: 20-9.
111. Ellwood P, Innes Asher M, García-Marcos L, et al. Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Thorax. 2013; doi: 10.1136/thoraxjnl-2012-202285.
112. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-70.
113. Ciardi C, Jenny M, Tschoner A, et al. Food additives sodium sulfite, sodium benzoate and curcumin inhibit leptin release in lipopolysaccharide-treated murine adipocytes in vitro. Br J Nutr 2012; 107: 826-33.
114. Wurtman RJ, Hefti F, Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol Rev 1980; 32: 315-35.
115. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005; 115: 897-909.
116. Hosick PA, Stec DE. Heme oxygenase, a novel target for the treatment of hypertension and obesity? Am J Physiol Regul Integr Comp Physiol 2012; 302: R207-14.
117. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine. Curr Drug Targets 2010; 11: 1485-94.
118. Sprenger H, Jacobs C, Nain M, et al. Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol 1992; 63: 188-95.
119. Tilz GP, Domej W, Diez-Ruiz A, et al. Increased immune activation during and after physical exercise. Immunobiology 1993; 188: 194-202.
120. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009; 106: 8665-870.
121. Radak Z, Chung HY, Koltai E, Taylor AW, Goto S. Exercise, oxidative stress and hormesis. Ageing Res Rev 2008; 7: 34-42.